Clinical trial
Evaluation Of Carboxytherapy As An Adjuvant To Narrowband-Ultraviolet B Phototherapy For The Treatment Of Stable Non-Segmental Vitiligo: A Clinical And Biochemical Study .
NCT07563049 is registered in ClinicalTrials.gov with Kasr El Aini Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation Of Carboxytherapy As An Adjuvant To Narrowband-Ultraviolet B Phototherapy For The Treatment Of Stable Non-Segmental Vitiligo: A Clinical And Biochemical Study .
- Lead sponsor
- Kasr El Aini Hospital
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- September 15, 2024
- Completion date
- June 1, 2026
- Enrollment
- 59 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
vitiligo vulgaris